OpinionOpen Access

Osteonecrosis of the Jaws: The Awareness of the Patient at Risk

Volume 1 - Issue 4

Édila Figuerêdo Feitosa Cavalcanti¹, Alessandra Oliveira Ferrari Gomes² and Sandra Regina Torres^2*

Author Information Open or Close
- ¹Department of Internal Medicine, Clementino Fraga Filho University Hospital, Universidade Federal do Rio de Janeiro, Brazil
- ²Department of Oral Pathology and Diagnosis, Dental School, Universidade Federal do Rio de Janeiro, Brazil
*Corresponding author: Departamento de Patologia e Diagnóstico Oral Faculdade de Odontologia (FO/UFRJ). Av. Carlos Chagas Filho, 373 - Prédio do CCS - Bloco K-2° andar-Sala 56. Ilha da Cidade Universitária-Rio de Janeiro/RJ-CEP: 21.941-902, Brazil

Received: August 24, 2017; Published: September 01, 2017

DOI: 10.26717/BJSTR.2017.01.000320

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Individuals under anti-angiogenic or antiresorptive bone medications are in risk to develop medication related osteonecrosis of the jaws (MRONJ). The most common trigger event that can lead to MRONJ is bone manipulation, such as dental extraction. Thus, a proposed consent form to be use by clinicians attending individuals at risk of development of MRONJ is proposed. Three clinicians with experience in dental treatment of individuals exposed to anti-angiogenic or antiresorptive-reabsortive bone medications developed a consent form based on technical and scientific content. A clear and simple text was elaborated for patient’s knowledge and consent registration. Clinicians should always inform patients about the condition and the risks of the procedures during dental treatment, and those individuals in risk to develop MRONJ should sign a consent form, before invasive procedures are performed.

Keywords: Jaws; Bisphosphonate-Associated Osteonecrosis of the Jaw; Consent Forms

Abbreviations: MRONJ: Medication Related Osteonecrosis of the Jaws

Abstract| Introduction| References|